Clinical Trial Update: Exploratory Study of Neoadjuvant Treatment of HER2-positive Breast Cancer With Py in Combination With HP [Phase 4]

View source ↗

Summary

Exploratory Phase 4 trial evaluating neoadjuvant treatment of HER2-positive breast cancer with Py in combination with HP.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HP
• Py

Snippet

Sponsor: Wuhan University | Conditions: Breast Cancer | Phase 4 | Status: NOT_YET_RECRUITING